Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Cancer × 1 year × Clear all

Phase

Phase NA 13 Phase 1 10 Phase 1/2 5 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 218 Carcinoma, Non-Small-Cell Lung 184 Prostatic Neoplasms 98 Neoplasms 88 Multiple Myeloma 73 Neoplasm Metastasis 62 Colorectal Neoplasms 58 Parkinson Disease 4, Autosomal Dominant Lewy Body 57 Lung Neoplasms 57 Ovarian Neoplasms 49 Leukemia, Myeloid, Acute 46 Melanoma 44 Carcinoma, Renal Cell 40 Carcinoma, Hepatocellular 39 Stomach Neoplasms 38 Brain Neoplasms 37 Recurrence 35 Squamous Cell Carcinoma of Head and Neck 34 Lymphoma, Follicular 33 Triple Negative Breast Neoplasms 32 Urinary Bladder Neoplasms 31 Myasthenia Gravis 31 Leukemia, Lymphocytic, Chronic, B-Cell 30 Colonic Neoplasms 30 Small Cell Lung Carcinoma 28 Head and Neck Neoplasms 28 Rectal Neoplasms 27 Nasopharyngeal Carcinoma 27 Pancreatic Neoplasms 26 Lymphoma, Non-Hodgkin 25

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed

794 enrolled 13 charts 1 FDA

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡